Science & Enterprise subscription

Follow us on Twitter

  • A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV… https://t.co/Gl4q8GAZBg
    about 2 hours ago
  • New post on Science and Enterprise: Sensor in Works Detecting Covid-19 Airborne Virus https://t.co/gQ7LuZ5Qv1 #Science #Business
    about 2 hours ago
  • A company designing microscale robotic devices to deliver therapies to the central nervous system began work in pub… https://t.co/SUbHXwULXG
    about 4 hours ago
  • New post on Science and Enterprise: Micro Robotic Neuro Therapy Company Underway https://t.co/Lfm9Nysgd3 #Science #Business
    about 4 hours ago
  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 1 day ago

Please share Science & Enterprise

AI Cell Analysis Start-Up Raises $6M Seed Funds

T lymphocyte

A new enterprise using artificial intelligence to analyze individual cells for immune-related diagnostics and therapies is raising $6 million in seed funds. . . . → Read More: AI Cell Analysis Start-Up Raises $6M Seed Funds

Grant Funds Brain Disease Tissue Banks

Neurons

An advocacy organization for neurodegenerative diseases and medical research foundation are sponsoring formation of a network to collect brain tissue samples. . . . → Read More: Grant Funds Brain Disease Tissue Banks

20 Precision Meds Approved by FDA in 2020

Syringe, pills, capsules

A report by a group advocating for precision medicine notes that the Food and Drug Administration approved 20 new personalized drugs and biologics in 2020. . . . → Read More: 20 Precision Meds Approved by FDA in 2020

AI Designs Better Gene Therapy Delivery Viruses

Adeno-associated virus

An academic-industry team used machine learning to design more effective variations of common benign viruses that deliver gene therapies. . . . → Read More: AI Designs Better Gene Therapy Delivery Viruses

Immune Response Shown in Alzheimer’s Vaccine

Brain activity graphic

Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine

AbbVie Licenses Engineered Crispr Cell Process

Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process

FDA Clears Covid-19 Dual-Antibody Therapy

SARS-Cov-2 viruses

The Food and Drug Administration granted an emergency authorization for a combination of two synthetic antibodies to treat non-hospitalized Covid-19 infections. . . . → Read More: FDA Clears Covid-19 Dual-Antibody Therapy

Smartwatch Shown to Offer Early Covid-19 Warning

Apple Watch

A study shows heart rate data captured by an Apple watch can provide an early warning of impending Covid-19 infections, even before a positive test. . . . → Read More: Smartwatch Shown to Offer Early Covid-19 Warning

Biotech, UK Govt to Design Covid-19 Variant Vaccines

Vaccine vials

A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines

Apple Watch Helps Personalize Parkinson’s Care

Operating a smart watch

A new study shows an Apple watch can capture data on tremors experienced by people with Parkinson’s disease to help provide more precise care. . . . → Read More: Apple Watch Helps Personalize Parkinson’s Care